The KIWOOM KOSEF US Blockbuster Biotech Drugs Plus ETF seeks to replicate as closely as possible the price and yield performance of the Solactive Blockbuster Biotech Drugs Index by investing in a portfolio comprised primarily of U.S. biotech companies
The KIWOOM KOSEF US Blockbuster Biotech Drugs Plus ETF (KRW) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Kiwoom AM fund’s base currency is KRW and the share class was registered 28.05.2024 with unique ISIN - KR7483030003. Main exchange is Korea Exchange and ticker symbol is 483030. The total expense ratio is 0.49%. The KIWOOM KOSEF US Blockbuster Biotech Drugs Plus ETF (KRW) pays dividends 1 time(s) per year.